Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of ROSSARI BIOTECH. For more details, see the ROSSARI BIOTECH quarterly results and ROSSARI BIOTECH share price.
1 Day | % | -2.0 |
No. of shares | m | 55.25 |
1 Week | % | 2.3 |
1 Month | % | 1.5 |
1 Year | % | 3.3 |
52 week H/L | Rs | 903.5/665.2 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ROSSARI BIOTECH EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | 1,146 | 1,621 | 1,051 | |
Low | Rs | NA | NA | 664 | 889 | 536 | |
Sales per share (Unadj.) | Rs | 1,173.2 | 118.2 | 136.6 | 269.3 | 300.2 | |
Earnings per share (Unadj.) | Rs | 103.8 | 12.9 | 15.4 | 17.7 | 19.4 | |
Diluted earnings per share | Rs | 8.3 | 11.8 | 14.5 | 17.7 | 19.4 | |
Cash flow per share (Unadj.) | Rs | 131.5 | 16.2 | 19.8 | 26.5 | 30.9 | |
Dividends per share (Unadj.) | Rs | 1.00 | 0.50 | 0.50 | 0.50 | 0.50 | |
Adj. dividends per share | Rs | 0.08 | 0.46 | 0.47 | 0.50 | 0.50 | |
Avg Dividend yield | % | 0 | 0 | 0.1 | 0 | 0.1 | |
Book value per share (Unadj.) | Rs | 281.4 | 56.4 | 78.3 | 145.6 | 165.3 | |
Adj. book value per share | Rs | 22.4 | 51.8 | 73.6 | 145.1 | 165.0 | |
Shares outstanding (eoy) | m | 4.40 | 50.75 | 51.93 | 55.06 | 55.16 | |
Price / Sales ratio | x | 0 | 0 | 6.6 | 4.7 | 2.6 | |
Avg P/E ratio | x | 0 | 0 | 58.7 | 70.7 | 40.8 | |
P/CF ratio (eoy) | x | 0 | 0 | 45.7 | 47.4 | 25.7 | |
Price / Book Value ratio | x | 0 | 0 | 11.6 | 8.6 | 4.8 | |
Dividend payout | % | 1.0 | 3.9 | 3.2 | 2.8 | 2.6 | |
Avg Mkt Cap | Rs m | 0 | 0 | 46,975 | 69,088 | 43,769 | |
Total wages/salary | Rs m | 275 | 372 | 420 | 679 | 986 |
ROSSARI BIOTECH INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 5,162 | 6,001 | 7,093 | 14,830 | 16,559 | |
Other income | Rs m | 9 | 37 | 92 | 191 | 139 | |
Total revenues | Rs m | 5,171 | 6,038 | 7,185 | 15,021 | 16,698 | |
Gross profit | Rs m | 776 | 1,045 | 1,235 | 1,778 | 2,155 | |
Depreciation | Rs m | 122 | 169 | 228 | 481 | 629 | |
Interest | Rs m | 29 | 36 | 30 | 127 | 223 | |
Profit before tax | Rs m | 634 | 878 | 1,068 | 1,363 | 1,442 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 177 | 226 | 268 | 386 | 370 | |
Profit after tax | Rs m | 457 | 653 | 800 | 977 | 1,073 | |
Gross profit margin | % | 15.0 | 17.4 | 17.4 | 12.0 | 13.0 | |
Effective tax rate | % | 27.9 | 25.7 | 25.1 | 28.3 | 25.6 | |
Net profit margin | % | 8.8 | 10.9 | 11.3 | 6.6 | 6.5 |
ROSSARI BIOTECH BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1,598 | 3,465 | 3,814 | 6,749 | 8,483 | |
Current liabilities | Rs m | 1,218 | 1,689 | 1,769 | 3,602 | 4,740 | |
Net working cap to sales | % | 7.4 | 29.6 | 28.8 | 21.2 | 22.6 | |
Current ratio | x | 1.3 | 2.1 | 2.2 | 1.9 | 1.8 | |
Inventory Days | Days | 33 | 47 | 42 | 36 | 33 | |
Debtors Days | Days | 61 | 57 | 74 | 75 | 78 | |
Net fixed assets | Rs m | 1,229 | 1,781 | 2,633 | 7,419 | 7,234 | |
Share capital | Rs m | 44 | 102 | 104 | 110 | 110 | |
"Free" reserves | Rs m | 1,194 | 2,760 | 3,963 | 7,909 | 9,006 | |
Net worth | Rs m | 1,238 | 2,862 | 4,067 | 8,019 | 9,117 | |
Long term debt | Rs m | 7 | 340 | 0 | 0 | 349 | |
Total assets | Rs m | 2,828 | 5,245 | 6,448 | 14,168 | 15,717 | |
Interest coverage | x | 23.0 | 25.7 | 36.7 | 11.8 | 7.5 | |
Debt to equity ratio | x | 0 | 0.1 | 0 | 0 | 0 | |
Sales to assets ratio | x | 1.8 | 1.1 | 1.1 | 1.0 | 1.1 | |
Return on assets | % | 17.2 | 13.1 | 12.9 | 7.8 | 8.2 | |
Return on equity | % | 36.9 | 22.8 | 19.7 | 12.2 | 11.8 | |
Return on capital | % | 53.2 | 28.5 | 27.0 | 18.6 | 17.6 | |
Exports to sales | % | 13.7 | 11.0 | 9.1 | 7.3 | 7.7 | |
Imports to sales | % | 16.8 | 16.0 | 18.8 | 12.6 | 5.2 | |
Exports (fob) | Rs m | 709 | 662 | 645 | 1,084 | 1,272 | |
Imports (cif) | Rs m | 867 | 959 | 1,336 | 1,862 | 857 | |
Fx inflow | Rs m | 709 | 662 | 645 | 1,084 | 1,272 | |
Fx outflow | Rs m | 900 | 959 | 1,336 | 1,862 | 857 | |
Net fx | Rs m | -191 | -296 | -691 | -778 | 416 |
ROSSARI BIOTECH CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 712 | 568 | 478 | 294 | 1,524 | |
From Investments | Rs m | -364 | -1,903 | -372 | -2,989 | -1,809 | |
From Financial Activity | Rs m | -292 | 1,569 | -246 | 2,918 | 609 | |
Net Cashflow | Rs m | 51 | 235 | -140 | 223 | 324 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Edward Menezes | COMP SEC: Parul Gupta | YEAR OF INC: 2003 | BSE CODE: 543213 | FV (Rs): 2 | DIV YIELD (%): 0.1 |
Read: ROSSARI BIOTECH 2022-23 Annual Report Analysis
More Chemicals & Pesticides Company Fact Sheets: UPL PIDILITE INDUSTRIES BALAJI AMINES BODAL CHEMICALS INDIA PESTICIDES
Compare ROSSARI BIOTECH With: UPL PIDILITE INDUSTRIES BALAJI AMINES BODAL CHEMICALS INDIA PESTICIDES
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.